Skip to main content

Nonalcoholic Fatty Liver Disease News (Page 2)

Related terms: Nonalcoholic Steatohepatitis, Idiopathic Fatty Liver, Steatosis, Steatohepatitis, Fatty Liver, NASH, NAFLD, MASLD, Metabolic Dysfunction-Associated Steatotic Liver Disease

FDA Approves First Drug for Common, Serious Liver Disease, Rezdiffra

FRIDAY, March 15, 2024 – Millions of Americans whose livers develop scar tissue due to a common disease now have the first approved drug, Rezdiffra, to treat the condition, the U.S. Food and Drug...

NASH Resolution Increased, Improvement of Fibrosis Seen With Resmetirom

THURSDAY, Feb. 8, 2024 – For patients with nonalcoholic steatohepatitis (NASH) and fibrosis stage F1B, F2, or F3, 80- and 100-mg resmetirom is better than placebo, according to a study published in...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

orlistat